ANIP
ANI Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
5.43 / 10
Netural
Fund flow analysis scores 7.61/10, indicating robust liquidity momentum. Small, Medium, and Large order flows show positive trends, offsetting a negative overall flow. Analyst sentiment is overwhelmingly bullish with a Strong Buy rating from one institution, yet the historical weighted rating of 3.24 suggests limited conviction. This combination implies potential upside if fundamentals improve, but current negative fundamentals and neutral technicals keep the risk-reward balanced.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-16
InstitutionGuggenheim
Times predicted6
Historical Win Rate33.3%
What is the analyst consensus for ANIP?
- ANIP holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.43/10 (Netural).
